Royal Bank of Canada’s Takeda Pharmaceutical TAK Stock Holding History

Royal Bank of Canada’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-966,100	Closed	-$15.2M	–	7574
2023 Q2	$15.2M	Buy	+966,100	New	+$15.8M	﹤0.01%	1317
2021 Q1	–	Sell	-3,000	Closed	-$55K	–	7685
2020 Q4	$55K	Sell	3,000 -322,000	-99%	-$5.65M	﹤0.01%	5623
2020 Q3	$5.8M	Hold	325,000	–	–	﹤0.01%	1899
2020 Q2	$5.83M	Hold	325,000	–	–	﹤0.01%	1826
2020 Q1	$4.93M	Hold	325,000	–	–	﹤0.01%	1815
2019 Q4	$6.41M	Hold	325,000	–	–	﹤0.01%	1973
2019 Q3	$5.59M	Hold	325,000	–	–	﹤0.01%	1994
2019 Q2	$5.75M	Buy	+325,000	New	+$5.91M	﹤0.01%	1964

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada's TAK Position: Q1 2026 in Review

Royal Bank of Canada increased its Takeda Pharmaceutical (TAK) stake by 11% in Q1 2026, buying an estimated $1.07M and bringing the position to 614,851 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Royal Bank of Canada first reported a position in TAK in Q4 2018 and has held it in 30 quarters since. 360 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Royal Bank of Canada held 614,851 shares of Takeda Pharmaceutical worth $11.4M as of Q1 2026.
Royal Bank of Canada bought 60,725 Takeda Pharmaceutical shares in Q1 2026, an estimated $1.07M.
Takeda Pharmaceutical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1820 holding.
Royal Bank of Canada first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 30 quarters since.
360 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.